Literature DB >> 19234514

Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder.

W Townsend, N C P Cross, K Waghorn, K Somana, A Ramsay, K Thomson, K Peggs.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19234514     DOI： 10.1038/bmt.2008.448

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  2 in total

1.  Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.

Authors:  M S Khodadoust; B Luo; B C Medeiros; R C Johnson; M D Ewalt; A S Schalkwyk; C D Bangs; A M Cherry; S Arai; D A Arber; J L Zehnder; J Gotlib
Journal:  Leukemia       Date:  2015-06-09       Impact factor: 11.528

2.  Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia.

Authors:  Karl Haslam; Stephen E Langabeer; Johanna Kelly; Natasha Coen; Niamh M O'Connell; Eibhlin Conneally
Journal:  Case Rep Hematol       Date:  2012-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.